drug drugs pharmaceutical products generic fda sales entry product research prescription therapeutic health effects marketing competition market otc rx

0.54 Mary K. Olson, Pharmaceutical Policy Change and the Safety of New Drugs, Journal of Law and Economics, 2002.
0.52 Henry Grabowski Y. Richard Wang, Do Faster Food and Drug Administration Drug Reviews Adversely Affect Patient Safety? An Analysis of the 1992 Prescription Drug User Fee Act, Journal of Law and Economics, 2008.
0.49 Davina C. Ling Ernst R. Berndt Margaret K. Kyle, Deregulating Direct‐to‐Consumer Marketing of Prescription Drugs: Effects on Prescription and Over‐the‐Counter Product Sales, Journal of Law and Economics, 2002.
0.41 Peter Temin, Realized Benefits from Switching Drugs, Journal of Law and Economics, 1992.
0.40 Tomas J. Philipson, The Regulation of Medical Innovation and Pharmaceutical Markets, Journal of Law and Economics, 2002.
0.38 John E. Calfee Clifford Winston Randolph Stempski, Direct‐to‐Consumer Advertising and the Demand for Cholesterol‐Reducing Drugs, Journal of Law and Economics, 2002.
0.38 David Dranove, Medicaid Drug Formulary Restrictions, Journal of Law and Economics, 1989.
0.37 Patricia M. Danzon Li‐Wei Chao, Does Regulation Drive out Competition in Pharmaceutical Markets?, Journal of Law and Economics, 2000.
0.36 John A. Rizzo, Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive Drugs, Journal of Law and Economics, 1999.
0.35 Frank R. Lichtenberg Tomas J. Philipson, The Dual Effects of Intellectual Property Regulations: Within‐ and Between‐Patent Competition in the US Pharmaceuticals Industry, Journal of Law and Economics, 2002.
0.33 Mark A. Hurwitz Richard E. Caves, Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals, Journal of Law and Economics, 1988.
0.32 Keith B. Leffler, Persuasion or Information? The Economics of Prescription Drug Advertising, Journal of Law and Economics, 1981.
0.32 Henry G. Grabowski John M. Vernon, Brand Loyalty Entry and Price Competition in Pharmaceuticals after the 1984 Drug Act, Journal of Law and Economics, 1992.
0.31 Patricia M. Danzon Mark V. Pauly, Health Insurance and the Growth in Pharmaceutical Expenditures, Journal of Law and Economics, 2002.
0.31 Henry Steele, Monopoly and Competition in the Ethical Drugs Market, Journal of Law and Economics, 1962.
0.30 Andrew A. Toole, Does Public Scientific Research Complement Private Investment in Research and Development in the Pharmaceutical Industry?, Journal of Law and Economics, 2007.
0.29 Jayanta Bhattacharya William B. Vogt, A Simple Model of Pharmaceutical Price Dynamics, Journal of Law and Economics, 2003.
0.29 William J. Moore Robert J. Newman, Drug Formulary Restrictions as a Cost-Containment Policy in Medicaid Programs, Journal of Law and Economics, 1993.
0.28 David Dranove Chris Olsen, The Economic Side Effects of Dangerous Drug Announcements, Journal of Law and Economics, 1994.
0.28 Peter Temin, The Origin of Compulsory Drug Prescriptions, Journal of Law and Economics, 1979.
0.26 Sam Peltzman, The Health Effects of Mandatory Prescriptions, Journal of Law and Economics, 1987.
0.25 Henry G. Grabowski John M. Vernon Lacy Glenn Thomas, Estimating the Effects of Regulation on Innovation: An International Comparative Analysis of the Pharmaceutical Industry, Journal of Law and Economics, 1978.
0.25 Carmelo Giaccotto Rexford E. Santerre John A. Vernon, Drug Prices and Research and Development Investment Behavior in the Pharmaceutical Industry, Journal of Law and Economics, 2005.
0.19 Richard L Manning, Products Liability and Prescription Drug Prices in Canada and the United States, Journal of Law and Economics, 1997.
0.18 Lester G. Telser William Best John W. Egan Harlow N. Higinbotham, The Theory of Supply with Applications to the Ethical Pharmaceutical Industry, Journal of Law and Economics, 1975.
0.16 Darius Lakdawalla Tomas Philipson, Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets, Journal of Law and Economics, 2012.